Research and Markets has announced the addition of the "Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues" conference to their ...
The FDA has released a copy of its Form 483, which outlines observed conditions at the New England Compounding Center in Framingham, Mass. The NECC is under investigation for contaminated products ...
Having noticed an uptick in medical device recalls and FDA warning letters to medtech companies this year, it seems an appropriate time to look back on a Form 483 from December 2016 that surprised ...
Considering the tight timeline for preparing responses to FDA compliance actions coupled with the agency’s expectation for timely implementation of corrective and preventive actions, the benefit of ...
ET Now on MSN
Exclusive | Dr Reddy's USFDA 5 observations from Srikakulam plant: Details from Form 483
Dr Reddy's Laboratories informed the stock exchanges on December 12, 2025, about the conclusion of the inspection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback